The present invention relates to novel cysteine protease inhibitors; the pharmaceutically acceptable salts and N-oxides thereof; their uses as therapeutic agents and the methods of their making.
Novel compounds and compositions as cathepsin inhibitors
申请人:Aventis Pharmaceuticals Inc.
公开号:US20040192742A1
公开(公告)日:2004-09-30
The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
Novel Compounds and Compositions as Cathepsin Inhibitors
申请人:Graupe Michael
公开号:US20070135386A1
公开(公告)日:2007-06-14
The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.